Genomics Market worth $85.09 billion by 2030
The report "Genomics Market by Product (Reagents, Kits, Instruments), Services (Genome Profiling, Bioinformatics), Technology (Sequencing, PCR, ISH, Flow Cytometry), Study Type (Epigenomics), Application (Drug Discovery, Diagnostics, Agri) - Global Forecast to 2030" The global genomics market is projected to grow from USD 47.07 billion in 2025 to USD 85.09 billion by 2030, registering a CAGR of 12.6% during the forecast period of 2025 to 2030. Several factors are driving the growth of the global genomics market. These include increased investments in genomics, the expansion of population genomics initiatives, and a heightened focus on rare and genetic diseases. Additionally, advancements in next-generation sequencing (NGS) platforms and the growing applications of genomics are contributing to market expansion. Key pharmaceutical companies are also investing more in personalized medicine research. Precision medicine enables healthcare practitioners to better understand patients' needs and prescribe treatments accordingly, resulting in improved care outcomes.
Browse 671 market data Tables and 68 Figures spread through 560 Pages and in-depth TOC on "Genomics Market by Product (Reagents, Kits, Instruments), Services (Genome Profiling, Bioinformatics), Technology (Sequencing, PCR, ISH, Flow Cytometry), Study Type (Epigenomics), Application (Drug Discovery, Diagnostics, Agri) - Global Forecast to 2030"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/genomics-market-613.html
The products segment accounted for the largest share of the genomics market in 2024.
By offerings, the genomics market is segmented into products and services. The products segment accounted for the largest share of the genomics market in 2024. The large share of the products segment can be attributed to innovations in genomics technology, such as long-read sequencing (LRS), single-cell genomics, and CRISPR technology, which have expanded product offerings and applications, thereby boosting demand for specialized products and technologies.
The functional genomics segment is estimated to register the highest CAGR from 2025 to 2030.
Based on study type, the genomics market has been segmented into functional genomics, biomarker discovery, pathway analysis, epigenomics, and other study types. In 2024, the functional genomics segment accounted for the largest market share. This segment is also expected to experience the fastest growth during the forecast period due to its essential role in identifying potential drug targets, particularly in fields such as cancer and genetic disorders. This critical nature is driving its widespread adoption in pharmaceutical research. Meanwhile, the biomarker discovery segment holds the second-largest share of the market.
Asia Pacific is likely to be the fastest-growing region in the genomics market during the forecast period.
Based on region, the genomics market is segmented into North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. The Asia Pacific is expected to register the fastest growth in the genomics market during the forecast period, driven by increasing government funding for genomic research, expanding healthcare infrastructure, and the rising adoption of precision medicine initiatives across major countries, including China, Japan, and India. Growing investments by global and regional players, coupled with a large patient pool for genetic and chronic diseases, further accelerate market expansion.
Key players in the genomics market include Illumina, Inc. (US), Thermo Fisher Scientific Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Danaher Corporation (US), QIAGEN (Germany), Agilent Technologies, Inc. (US), Revvity, Inc. (US), Laboratory Corporation of America Holdings (US), IQVIA Inc. (US), Charles River Laboratories (US), Bio-Rad Laboratories, Inc. (US), Eurofins Scientific (Luxembourg), PacBio (US), Oxford Nanopore Technologies Plc. (UK), Takara Bio Inc. (Japan), BGI Group (China), Eppendorf SE (Germany), Merck KGaA (Germany), BD (US), Abbott (US), 10X Genomics, Inc. (US), New England Biolabs (US), Promega Corporation (US), Creative Biogene (US), Novogene Co., Ltd. (China), Helix, Inc. (US), Phalanx Biotech Group (US), and Polaris Genomics (US).
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Genomics Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
